Background: Macrophage immune responses are affected by the secretory proteins of Mycobacterium tuberculosis (Mtb). This study aimed to examine the immune responses of macrophages to Mtb secretory antigens, namely ESAT-6, CFP-10, and ESAT-6/ CFP-10. Methods: THP-1 cells (a human monocytic cell line) were cultured and differentiated to macrophages by phorbol 12-myristate 13-acetate. The cytotoxicity of the recombinant Mtb proteins was assessed using the MTT assay. Two important immune responses of macrophages, namely NO and ROS production, were measured in response to the ESAT-6, CFP-10, and ESAT-6/CFP-10 antigens. The data were analyzed using one-way ANOVA with SPSS, version 16, and considered significant at P<0.05.
Introduction
Tuberculosis (TB) is a public health challenge that contributes to the illness and death of 2-3 million people every year around the world. About one-third of the world's population has latent TB. Individuals with latent TB are defined as those who possess TB bacteria but have yet to demonstrate the clinical signs of the disease. The state of being infected by TB bacteria brings about a 10% lifetime risk of illness, more so in those with immune defects,
Original Article What's Known
• Mycobacterium tuberculosis (M. tb) pathogenesis is dependent on T cells and macrophage response to mycobacterium antigens. ESAT-6 and CFP-10 are 2 secretory antigens affecting the host's immune response. Immune response against M. tb plays a key role in the outcome of TB infection.
What's New
• ESAT-6 and CFP-10 inhibited 2 important arms of immune response in macrophages, ROS and NO production, through direct effects on iNOS enzyme activity.
• This effect was notable in the ESAT-6/CFP-10 protein in comparison with the antigens alone. Very low concentrations of ESAT-6/CFP-10 suppressed macrophage immune response without any side effect on cell viability.
HIV infection, malnutrition, diabetes, or smoking habits. 1 TB accounts for about 3 million deaths, with 9 million new cases of the disease diagnosed each year. According to the reports by the World Health Organization (WHO), 95% of the cases occur in developing countries. 1 In Iran, the trend of TB is decreasing and in 2013, the incidence rate was 13.7 per 100,000 population. 2 The immune response against TB plays a fundamental role in the outcome of Mycobacterium tuberculosis (Mtb) infection. The Mtb genome (H37Rv) has 4,019 genes coding for various proteins (Mtb genes), from which more than a quarter have been categorized as hypothetical in resources such as TubercuList. 3, 4 Two secreted proteins, namely 6-kDa early secreted antigen target (ESAT-6) and 10-kDa culture filtrate protein (CFP-10), encoded from the region of difference 1 (RD1) in the Mtb genome, play important roles in the pathogenesis of TB in primary pulmonary infection. 5 ESAT-6 and CFP-10 are recognized as important stimulators of T cells both in vitro and in vivo. 6 During the early stages of human TB infection, Mtb induces an immune response leading to lung granulomas consisting of macrophages, T cells, B cells, and fibroblasts. 7 Mtb mainly targets macrophages as hosts, and the following immune dysfunction of the infected macrophages is pathognomonic to TB. 8 Phagocytic cells such as macrophages are among the most important components of the innate immune response, which is the first line of host defense. Reactive oxygen species (ROS) and nitric oxide (NO), generated from the nicotinamide adenine dinucleotide phosphate (NADPH) phagocyte oxidase and inducible nitric oxide synthase (iNOS) pathways, respectively, are 2 of the most important antimicrobial systems of phagocytic cells. 9, 10 Macrophages are the main cells playing a role in phagocytosis and presenting mycobacterial antigens to T cells. Specific receptors on T lymphocytes recognize the antigens and release activation signals that induce the production of cytokines such as interferon gamma (IFN-γ).
11 This cytokine acts with some mycobacterial compounds to promote macrophage activation. 12 The first interaction between macrophages and Mtb is thought to play a key role in determining the outcome of infection. Bacterial products are recognized by receptors on macrophages. These receptors include CD14 and Toll-like receptors (TLRs), which rapidly signal the presence of the pathogen through the transcription nuclear factor-kB (NF-kB), resulting in the transcription of macrophage genes responsible for an effective immune response. 13 NADPH phagocyte oxidase and iNOS are expressed in both polymorphonuclear and mononuclear phagocytes, although the amount of ROS produced is greater in neutrophils than that in macrophages, and macrophages generally produce considerably more reactive nitrogen species (RNS) than do neutrophils.
10,14 RNS such as NO are required for the destruction of intracellular Mtb bacilli in a murine model. 15, 16 The effector mechanisms involved in direct Mtb killing or infected cell lysis by CD4 + T and CD8 + T lymphocytes have been previously described. 17, 18 However, Mtb can still survive in macrophages. Despite progress in understanding the pathogen-host relationship, the mechanisms of the protection against and the pathogenesis of this disease remains unclear. This study aimed to investigate NO and ROS production in response to the recombinant secretory antigens of Mtb: ESAT-6, CFP-10, and ESAT-6/CFP-10.
Materials and Methods

Cell Culture
The cells were cultured at 1-4×10 6 cells/mL in RPMI 1640 (Biosera, Kansas City, USA), containing 10% heat-inactivated FBS, 100 U/mL of penicillin, and 100 µg/mL of streptomycin, and maintained at 37 o C under 5% CO 2 . In all the experiments, THP-1 (Pasteur Institute, Tehran, Iran) monocytic cells (1×10 6 cells) were differentiated into macrophages in a T25 Cell Culture Flask containing 3 mL of an RPMI 1640 medium with 5 ng/mL of phorbol 12-myristate 13-acetate (PMA) (Sigma, Dorset, P8139, UK) over 48 hours.
In vitro Experiments
Differentiated THP-1 macrophages have previously been advocated as an in vitro model of human macrophages. In accordance with the instruction manual by Park et al. 19 (protocol), the minimal PMA concentration of 5 ng/mL was applied for stable differentiation without undesirable gene upregulation. The ESAT-6, CFP-10, and ESAT-6/CFP-10 recombinant proteins used in this study were cloned in our laboratory. 20, 21 Cytotoxicity Assay: Reduction in Formazan Dye (3-[4,5- 
Cytotoxicity was assessed by the MTT assay. The differentiated THP-1 cells (1×10 5 cells/mL) were seeded in a 96-well plate in triplicate and preincubated for 12 hours for cell attachment. Then, 100 mL of a fresh medium containing various concentrations of ESAT-6 (2.5, 5, and 10 µg/mL), CFP-10 (2.5, 5, and 10 µg/mL), or ESAT-6/CFP-10 (1.25, 2.5, and 5 µg/mL) was added to the flat-bottomed 96-well microtiter tissue culture plates. The cells were incubated with each compound at 37°C for 24 hours under humidified air containing 5% CO 2 . Cell survival was evaluated by adding 100 mL of tetrazolium salt solution (1 µg of MTT/mL in PBS). After 4 hours of incubation at 37°C, 100 mL of DMSO was added to dissolve the precipitates of the reduced MTT. The microplate was shaken for 15 minutes, and absorbance was determined at 570 nm in a multi-well plate reader (FLUOstar OPTIMA spectrofluorometer, BioTek Synergy HT, USA). The cytotoxic effects of the recombinant proteins, namely ESAT-6, CFP-10, and ESAT-6/CFP-10, were examined for the study via the application of different concentrations of each of the recombinant proteins. The THP-1 cells were treated with the recombinant proteins at concentrations of 2.5, 5, and 10 µg/mL for ESAT-6 or CFP-10; 1.25, 2.5, and 5 µg/mL for ESAT-6/CFP-10; and 5 µg/mL for lipopolysaccharide (LPS, Sigma, Dorset, L3024, UK) overnight.
Detection of ROS Production by Spectrofluorimetry
The intracellular production of ROS was assessed using 2′,7′ dichlorofluorescein diacetate (DCF-DA, Sigma, Dorset, D6883, UK) in 96-well plates. The optimum concentrations of the recombinant proteins, namely ESAT-6, CFP-10, and ESAT-6/CFP-10, for this study were determined by the application of different concentrations of each of the recombinant proteins. The differentiated THP-1 cells (3×10 5 cells/well) were treated with different concentrations of ESAT-6 (10 µg/mL), CFP-10 (2.5 µg/mL), and ESAT-6/ CFP-10 (1.25 µg/mL). LPS with a concentration of 5 µg/mL was used as a positive control. Subsequently, LPS plus ESAT-6, CFP-10, and ESAT-6/CFP-10 were incubated for 60 minutes at 37°C. Then, they were exposed to 10 µM of DCFDA in PBS − (phosphate-buffered saline without calcium and magnesium) for 15 minutes at 37°C in the dark. The cells were washed with PBS − , and fluorescence was measured with a multi-well plate reader (FLUOstar OPTIMA Spectrofluorometer, BioTek, Synergy HT, USA), using filters with an excitation spectrum of 480 nm and emission of 520 nm.
NO Production Assessment
After incubating the differentiated THP-1 cells with ESAT-6 (2.5 µg/mL), CFP-10 (2.5 µg/mL), ESAT-6/CFP-10 (1.25 µg/mL), LPS (as a positive control, 5 µg/mL), and LPS plus ESAT-6, CFP-10, and ESAT-6/CFP-10 for 24 hours, the supernatants were removed from the cultures. Nitrite accumulation in the supernatant was measured as a sign of NO production, based on the Griess reaction. 20 A 50-mL aliquot of each supernatant was mixed with the same volume of the Griess reagent (1% sulfanilamide in 5% phosphoric acid and 0.1% naphthylethylenediamine dihydrochloride in water), incubated at room temperature for 10 minutes, and absorbance was measured at 540 nm using an enzyme-linked immunosorbent assay reader. The amount of nitrite produced was determined via a sodium nitrite standard curve.
iNOS Enzyme Assay
The THP-1 cells were differentiated in a 24-well plate (1×10 6 cells) with PMA for 24 hours. Differentiation was verified by observing morphological changes in the cells before treating them with the recombinant proteins, namely ESAT-6 (2.5 µg/mL), CFP-10 (2.5 µg/mL), ESAT-6/CFP-10 (1.25 µg/mL), and LPS (5 µg/mL), for 24 hours. The cells were scraped into cold PBS − and centrifuged. The cell pellets were resuspended in 0.5 mL of 40-mM Tris-buffer (pH=8.0) containing 5 µg/mL of pepstatin A, 5 µg/mL of aprotinin, and 100 mM of phenylmethylsulfonyl fluoride and were lysed by 3 freeze-thaw cycles. The cell lysate proteins were incubated in 20-mM Tris-HCl, containing FAD, tetrahydrobiopterin, and NADPH. The reaction was performed in duplicate for 180 minutes at 37°C in 96-well plates. iNOS activity was blocked using EDTA, and the Griess assay was performed. iNOS activity in the THP-1 cell lysate in the presence or absence of the recombinant proteins and LPS was determined and expressed as mol sulfanilamide oxidized/ minute/mg protein. The extracted protein was quantified using a commercially available kit (Pierce BCA Protein Assay Kit, Thermo Scientific, Rockford, USA) following the manufacturer's instructions. Absorbance was measured at 560 nm on a multi-well plate reader (FLUOstar OPTIMA spectrofluorometer, BioTek, Synergy HT, USA), and the total protein per sample was calculated in micrograms (μg).
Statistical Analysis
All the experiments were repeated independently 3 times. The results are expressed as mean ± SD. The data were analyzed using oneway ANOVA with SPSS, version 16 (SPSS Inc., Chicago, IL, USA). The statistical significance of differences in the mean levels of ROS, NO, etc. between the control and treatment groups was evaluated using the Student t-test. P values≤0.05 were considered significant. Graphs were drawn with GraphPad Prism, version 5 (GraphPad Software Inc., La Jolla, CA, USA).
Results
Cytotoxic Effect of Recombinant Secretory Proteins on THP-1 Cells
The results from the MTT assay showed that more than 80% of the THP-1 cells were viable and metabolically active in the presence of the recombinant proteins at the used concentrations. In other words, THP-1 cell viability in the presence of the different concentrations of the recombinant proteins remained unchanged ( figure 1) .
As is shown in figure 1 , the viability of the differentiated THP-1 cells in the presence of the recombinant proteins and LPS was more than 85%, demonstrating that these proteins had no significant toxic effect on cell viability. Figure 2 shows that the optimum concentrations for the recombinant ESAT-6, CFP-10, and ESAT-6/ CFP-10 proteins were 10, 5, and 1.25 µg/mL, respectively. The recombinant ESAT-6, CFP-10, and ESAT-6/CFP-10 proteins downregulated ROS production in the differentiated THP-1 cells in less than 60 minutes in all the concentrations applied. Downregulation by recombinant ESAT-6/ CFP-10 in its optimum concentration (60%) was greater than that observed for ESAT-6 (50%) or CFP-10 (40%) alone. ESAT-6 and CFP-10 showed similar effects on the downregulation of ROS production.
Effect of Different Recombinant Secretory Antigens on ROS Production in Macrophages
The effect of these recombinant proteins on LPS-induced ROS was also assayed. As is shown in figure 3 , the ESAT-6 protein (10 µg/mL) inhibited LPS-induced ROS production in the THP-1 cells by 60%, CFP-10 protein (5 µg/mL) by 50%, and ESAT-6/CFP-10 protein (1.25 µg/mL) by 70%. Therefore, the ESAT-6/CFP-10 proteins showed higher downregulating effects of LPSinduced ROS production at a lower concentration (1.25 µg/mL) than that of ESAT-6 or CFP-10 individually. Figure 4 illustrates that the concentrations of 2.5, 2.5, and 1.25 µg/mL were optimal for the recombinant ESAT-6, CFP-10, and ESAT-6/ CFP-10 proteins, respectively. The NO production results in the differentiated THP-1 cells showed that all of these proteins downregulated NO after 24 hours of treatment. Although a significant difference (P<0.05) was observed in the NO level between the cells treated with the recombinant proteins and the control, the NO levels for the ESAT-6, CFP-10, and ESAT-6/CFP-10 treatments at the optimal concentration were almost similar. Figure 5 depicts the effects of these recombinant proteins on LPS-induced NO production. The ESAT-6, CFP-10, and ESAT-6/ CFP-10 proteins at their optimum concentrations inhibited LPS-induced NO production in the THP-1 cells by 50-60%. These proteins showed similar effects on LPS-induced NO generation, and no significant difference was observed among these protein treatments. Table 1 demonstrates the effects of the recombinant ESAT-6, CFP-10, and ESAT-6/ CFP-10, and ESAT-6/CFP-10. Our results showed that the recombinant ESAT-6, CFP-10, and ESAT-6/CFP-10 proteins inhibited ROS and NO production in differentiated THP-1 cells. ROS and NO are 2 key elements involved in antimicrobial macrophage-mediated host defense. 10 ROS seem to play a significant role in host defense during intramacrophage infection against bacteria by oxidizing the -SH group of cysteine in proteins. 22 Another important microbiocidal function of macrophages is the generation of highly reactive free radical NO by iNOS.
Effects of Different Recombinant Secretory Proteins on Macrophage NO and iNOS Enzyme Activity
Effect of Recombinant Proteins on iNOS Enzyme Activity in Macrophages
23 LPS-induced oxidative burst in macrophages assists in killing invading pathogens. 24, 25 Macrophages respond to LPS by phosphorylating many intracellular signaling molecules. 24, 26, 27 This initiates a cascade of signaling events, leading to the secretion of inflammatory cytokines such as IL-1, IL-6, tumor necrosis factor alpha (TNF-α), and antimicrobial immune responses. 28 Trajkovic et al. 29 (2002) showed that CFP-10 was able to bind to the surface of mouse J774 macrophage-like cells and stimulate the secretion of the proinflammatory cytokine TNF-α, but it markedly reduced NO release on subsequent stimulation with LPS or Mtb cell lysate. That study also showed that CFP-10 blocked the shift in the cellular equilibrium toward signal activation by inhibiting ROS generation via LPS. In other words, inhibiting LPS-induced ROS by CFP-10 worked as a "control switch" that regulated consequent events. 30, 31 ROS activate NF-kB, which leads to gene transcription. 32 NF-kB plays a role in containing CFP-10 proteins on iNOS enzyme activity in the differentiated THP-1 cells. The treatment of the differentiated THP-1 cells with LPS (5 µg/mL) significantly increased iNOS enzyme activity over 24 hours (P<0.05), while the recombinant proteins significantly suppressed the effects of LPS on iNOS enzyme activity to nearly the same level as that in the control (table 1) .
Discussion
The current study aimed to investigate NO and ROS production in response to the recombinant secretory antigens of Mtb, namely ESAT-6, infection by inducing the expression of several proinflammatory cytokines such as TNF-α, IL-12, IFN-γ, and iNOS; therefore, it is critically targeted by pathogens. 33 Ganguly et al.
22
(2008) showed that ESAT-6, CFP-10, and the CFP-10/ESAT-6 complex downregulated NF-kB-dependent reporter gene expression by inhibiting ROS production in RAW264.7 cells. It has been reported that ESAT-6 may inhibit the innate immune response through a diminished production of the IL-12 p40 chain, TNF-α, and NO. 34 Pathak et al. 35 (2007) showed that ESAT-6 or its peptide-derived diminished TLR signaling by preventing the assembly of the cytosolic MyD88-dependent signaling scaffold and led to inhibited NF-kB activation, thereby attenuating the immune response in macrophages. Our results also showed that the recombinant ESAT-6, CFP-10, and the ESAT-6/CFP-10 proteins inhibited the production of ROS intermediates, which agreed with the results of Ganguly et al. 22 (2008) . Because NF-kB induces the expression of iNOS, the suppression of ROS leads to the suppression of transcription factor NF-kB and iNOS expression. Intracellular pathogens such as Mtb use a repertoire of dampening signals to subvert the innate immune response. ESAT-6 has emerged as a likely candidate for the investigation of its effect on macrophages, based on the finding that inactivating the esat-6 gene in Mtb increases the innate immune response and increases the production of IL-12 p40, IL-1α, TNF-α, and NO. 34, 36 The direct interaction between TLR2 and ESAT-6 inhibits the assembly of TLR-signaling molecules required for activating the innate immune response, but it is unclear whether ESAT-6/CFP-10 acts through a similar mechanism to suppress macrophage responses. 35 However, it is worthy to examine the possible involvement of other receptors in recombinant Mtb antigen-induced macrophage deactivation. Gupta et al. 37 (2010) showed that other recombinant Mtb antigens such as Rv1483 and Rv3416 suppressed TLR2-induced IL-12, ROS, and iNOS synthase expression during infection. The inhibited production of NO in the present study may be the result of inhibited ROS by the recombinant ESAT-6, CFP-10, and ESAT-6/CFP-10 antigens. The downregulation of ROS by these recombinant proteins affects iNOS expression via NF-kB. 22 It seems that downregulating ROS also affects iNOS activity, as was shown in our results (table 1). Our NO level findings in the THP-1 treated cells confirmed the iNOS activity results. Thus, the decrease in the NO level in the THP-1 treated cells could be due to the inhibition of the NF-kB signaling pathway 23 or the direct inhibition of iNOS activity (table 1) . In addition, the mycobacterial secretory protein ESAT-6 inhibits the expression of c-Myc, a key factor in macrophage activation. 38 These findings emphasize the role of ESAT-6 in deactivating macrophages, which are the host cells for Mtb. It seems that intracellular pathogens such as Mtb can evade the host immune response by inducing granuloma formation and suppressing the macrophage immune response. A study of the interactions between Mtb antigens such as ESAT-6 and host proteins leads us to an understanding of the mechanism of action between these two. As it is unclear whether CFP-10 and ESAT-6/CFP-10 act in such a way, identifying the mechanism of the action of Mtb antigens in host cells may offer promising alternatives to control TB infection and associated immunopathology.
The results of the current study also implied that the recombinant ESAT-6 and CFP-10 antigens helped Mtb evade the macrophage immune response by suppressing macrophage activation (production of ROS and NO), similar to other Mtb antigens such as Rv1483 and Rv3416. 37 That Mtb escapes mechanisms from the host immune system in order to stay hidden is a vital topic and a subject of interest in this field. Therefore, one of the concerns of our research team was to investigate the role of TLR and signaling pathways that could play an important role. In this regard, finding and determining the role of proteins involved in the signaling of TLR on the surface of macrophages can be useful. In future studies, we will aim to determine the interactions between signaling proteins and secretory antigens, which were a subject of this research, with a view to achieving a better understanding of the functions of immune cells when exposed to Mtb. 
Conclusion
It seems that the decline in the macrophage immune response is due to the suppression of NO and ROS production pathways by the modulation of gene expression without any effect on cell viability. The ESAT-6, CFP-10, and ESAT-6/CFP-10 proteins suppressed iNOS enzyme activity, which is notable for the fusion protein. The ESAT-6/CFP-10 fusion protein showed more suppressive effects at a low concentration than did ESAT-6 and CFP-10 alone. The possibility of crosstalk between receptors on macrophages such as TLRs and integrins and whether Mtb antigens result in downstream signaling are other issues that need further investigations. The findings of this study and those from others highlight the need for more research to understand the mechanism of action of Mtb antigens in host cells, which in turn, will open the door to future studies.
